4.6 Article

Comparison between free β subunit of human chorionic gonadotropin (hCG) and total hCG assays in adults with testicular cancer

期刊

CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 61, 期 10, 页码 1841-1849

出版社

WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2022-1240

关键词

free beta hCG; human chorionic gonadotropin; non-seminomatous germ cell tumour; seminoma; testicular cancer; tumour marker

向作者/读者索取更多资源

We compared the diagnostic sensitivity of beta hCG with total hCG assays in testicular cancer patients. Discordant results were common, with isolated increases of hCGt observed in 15.7% of patients and beta hCG in 6.9% of patients. Primary hypogonadism was the most common cause of isolated hCGt increases. Beta hCG decreased more rapidly below its upper reference than hCGt after therapeutic interventions.
Objectives: We tested the hypothesis that the free-beta subunit (beta hCG) is diagnostically more sensitive with total hCG assays (hCGt) not detecting all tumours secreting beta hCG. The effects of sex, age, and renal failure were investigated as secondary objectives. Methods: We compared beta hCG with hCGt in 204 testicular cancer patients (99 seminomas, 105 non-seminonatous germ cell tumours). The effects of sex and age were determined in 125 male and 138 female controls and that of renal failure was investigated in 119 haemodialysis patients. Biochemical assessment of gonadal status was performed with LH, FSH, oestradiol and testosterone. Results: Discordant results were common with isolated increases of hCGt observed in 32 (15.7 %) and beta hCG in 14 (6.9 %) patients. Primary hypogonadism was the most common cause of isolated hCGt increases. After therapeutic interventions beta hCG decreased below its upper reference more rapidly than hCGt. We observed unequivocal false negative results in two patients with non-seminomatous germ cell tumours. Both occurred in patients with clinical tumour recurrences; in one instance we observed a false negative hCGt while in the second false negative beta hCG's were documented in serial samples. Conclusions: The similar false negative rates did not support the hypothesis that beta hCG will detect more patients with testicular cancer than hCGt. In contrast to hCGt, beta hCG was unaffected by primary hypogonadism which is a predictably frequent complication in testicular cancer patients. We therefore recommend beta hCG as the preferred biomarker in testicular cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据